European Archives - Page 64 of 1369 - European Medical Journal

Evidence-Based Treatment of mCRPC

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor of…

Review of the European Society for Medical Oncology (ESMO) Congress 2025

THE EUROPEAN Society for Medical Oncology (ESMO) Congress 2025 took place in Berlin, Germany, a dynamic epicentre…

Established Therapies and Emerging Modalities in Lung Cancer

Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy regimens to…

The Evolving Biomarker Landscape in GI Cancers

First-Line Advances in TNBC: Datopotamab Deruxtecan and Sacituzumab Govitecan at ESMO 2025

THIS YEAR, the field of triple-negative breast cancer (TNBC) has witnessed significant advancements in the first line…

Nutrition in Oncology

During this symposium at the European Society of Medical Oncology (ESMO) Congress 2025, leading experts in oncology and nutrition…

AI and Cancer Care

AI WAS a highlight of the 2025 European Society for Medical Oncology (ESMO) Congress, held in Berlin, Germany, with sessions focused…

New Horizons in Anal Cancer and CRC

Anal and colorectal cancers are complex gastrointestinal malignancies that continue to pose therapeutic and diagnostic challenges…

The New Frontiers of Personalised Cancer Prevention

THIS YEAR, the highly anticipated European Society for Medical Oncology (ESMO) Congress 2025 was held in Berlin, Germany…

Multi-omics Insights for Biomarkers in NSCLC

Lung cancer remains the most frequently diagnosed malignancy and the leading cause of cancer tumour-related mortality worldwide…